649 results on '"Després, Jean-Pierre"'
Search Results
2. Adiposity, type 2 diabetes and atherosclerotic cardiovascular disease risk: Use and abuse of the body mass index
3. Substituting Refined Sugars With Maple Syrup Decreases Key Cardiometabolic Risk Factors in Individuals With Mild Metabolic Alterations: A Randomized, Double-Blind, Controlled Crossover Trial
4. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
5. 20-Year Trends in Metabolic Syndrome Among Korean Adults From 2001 to 2020
6. Leisure-time physical activity is more strongly associated with cardiometabolic risk than occupational physical activity: Results from a workplace lifestyle modification program
7. Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases
8. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases
9. Management of Obesity in Cardiovascular Practice: JACC Focus Seminar
10. Should we target increased physical activity or less sedentary behavior in the battle against cardiovascular disease risk development?
11. Long-Term Improvement in Cardiorespiratory Fitness Ameliorates Insulin Sensitivity beyond Changes in Visceral/Ectopic Fat among Men with Visceral Obesity.
12. The HERITAGE Family Study: A Review of the Effects of Exercise Training on Cardiometabolic Health, with Insights into Molecular Transducers
13. Relationships between circulating 25(OH) vitamin D, leptin levels and visceral adipose tissue volume: results from a 1-year lifestyle intervention program in men with visceral obesity
14. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
15. Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?
16. Changes in IGFBP-2 levels following a one-year lifestyle modification program are independently related to improvements in plasma apo B and LDL apo B levels
17. Effects of CB1R inverse agonist, INV‐202, in patients with features of metabolic syndrome. A randomized, placebo‐controlled, double‐blind phase 1b study.
18. Trunk muscle quality assessed by computed tomography: Association with adiposity indices and glucose tolerance in men
19. Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves
20. The relationship between yogurt consumption, body weight, and metabolic profiles in youth with a familial predisposition to obesity
21. The relationship between adiposopathy and glucose-insulin homeostasis is not affected by moderate-intensity aerobic training in healthy women with obesity
22. Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort
23. Relation Between a Simple Lifestyle Risk Score and Established Biological Risk Factors for Cardiovascular Disease
24. Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial
25. Plasma IGFBP-2 levels reveal heterogeneity in hepatic fat content in adults with excess visceral adiposity.
26. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases
27. One-Year Lifestyle Intervention, Muscle Lipids, and Cardiometabolic Risk
28. Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease
29. Yogurt consumption, body composition, and metabolic health in the Québec Family Study
30. Does Milk Consumption Contribute to Cardiometabolic Health and Overall Diet Quality?
31. Physical Activity, Sedentary Behaviours, and Cardiovascular Health: When Will Cardiorespiratory Fitness Become a Vital Sign?
32. The Underestimated Belly Factor: Waist Circumference Is Linked to Significant Morbidity Following Isolated Coronary Artery Bypass Grafting
33. The effects of exercise on the lipoprotein subclass profile: A meta-analysis of 10 interventions
34. Sex-Specific Impact of Body Weight on Atherosclerotic Cardiovascular Disease Incidence in Individuals With and Without Ideal Cardiovascular Health.
35. Obesity and Cardiovascular Disease: Weight Loss Is Not the Only Target
36. Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study)
37. Rosiglitazone influences adipose tissue distribution without deleterious impact on heart rate variability in coronary heart disease patients with type 2 diabetes
38. Short sleep duration as a risk factor for the development of the metabolic syndrome in adults
39. The Genetic and Metabolic Determinants of Cardiovascular Complications in Type 2 Diabetes: Recent Insights from Animal Models and Clinical Investigations
40. Is There a Role for Visceral Adiposity in Inducing Type 2 Diabetes Remission in Severely Obese Patients Following Biliopancreatic Diversion with Duodenal Switch Surgery?
41. Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study
42. Short sleep duration is associated with greater alcohol consumption in adults
43. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity
44. Influence of obesity indices, metabolic parameters and age on cardiac autonomic function in abdominally obese men
45. Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity
46. Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in women
47. In Memoriam: Denis Richard 1953–2023.
48. Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary)
49. Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group
50. Adiponectin and Risk of Coronary Heart Disease in Apparently Healthy Men and Women (from the EPIC-Norfolk Prospective Population Study)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.